ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Fundamental Analysis & Valuation

NASDAQ:ZBRA • US9892071054

211.77 USD
-7.88 (-3.59%)
Last: Mar 9, 2026, 12:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ZBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

ZBRA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While ZBRA has a great profitability rating, there are some minor concerns on its financial health. ZBRA may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. ZBRA Profitability Analysis

1.1 Basic Checks

  • In the past year ZBRA was profitable.
  • ZBRA had a positive operating cash flow in the past year.
  • In the past 5 years ZBRA has always been profitable.
  • ZBRA had a positive operating cash flow in 4 of the past 5 years.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.93%, ZBRA is in the better half of the industry, outperforming 70.16% of the companies in the same industry.
  • ZBRA's Return On Equity of 11.68% is fine compared to the rest of the industry. ZBRA outperforms 76.61% of its industry peers.
  • ZBRA has a better Return On Invested Capital (9.50%) than 80.65% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ZBRA is in line with the industry average of 8.67%.
  • The 3 year average ROIC (9.08%) for ZBRA is below the current ROIC(9.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROIC 9.5%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • ZBRA has a better Profit Margin (7.77%) than 77.42% of its industry peers.
  • In the last couple of years the Profit Margin of ZBRA has declined.
  • ZBRA's Operating Margin of 14.83% is amongst the best of the industry. ZBRA outperforms 86.29% of its industry peers.
  • ZBRA's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of ZBRA (48.05%) is better than 82.26% of its industry peers.
  • In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ZBRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
  • The number of shares outstanding for ZBRA has been reduced compared to 1 year ago.
  • ZBRA has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZBRA is higher compared to a year ago.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ZBRA has an Altman-Z score of 3.13. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ZBRA (3.13) is comparable to the rest of the industry.
  • ZBRA has a debt to FCF ratio of 3.01. This is a good value and a sign of high solvency as ZBRA would need 3.01 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 3.01, ZBRA is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • A Debt/Equity ratio of 0.66 indicates that ZBRA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ZBRA (0.66) is worse than 81.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Altman-Z 3.13
ROIC/WACC1.07
WACC8.85%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that ZBRA may have some problems paying its short term obligations.
  • ZBRA has a worse Current ratio (0.97) than 91.94% of its industry peers.
  • ZBRA has a Quick Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZBRA has a Quick ratio of 0.58. This is amonst the worse of the industry: ZBRA underperforms 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.58
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZBRA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.25% over the past year.
  • Measured over the past 5 years, ZBRA shows a small growth in Earnings Per Share. The EPS has been growing by 4.34% on average per year.
  • ZBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.33%.
  • The Revenue has been growing slightly by 3.94% on average over the past years.
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%

3.2 Future

  • ZBRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.22% yearly.
  • ZBRA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.44% yearly.
EPS Next Y14.52%
EPS Next 2Y13.55%
EPS Next 3Y13.11%
EPS Next 5Y15.22%
Revenue Next Year11.43%
Revenue Next 2Y8.45%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

8

4. ZBRA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.37, the valuation of ZBRA can be described as correct.
  • ZBRA's Price/Earnings ratio is rather cheap when compared to the industry. ZBRA is cheaper than 87.90% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, ZBRA is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 11.67 indicates a reasonable valuation of ZBRA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZBRA indicates a rather cheap valuation: ZBRA is cheaper than 86.29% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.60. ZBRA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.37
Fwd PE 11.67
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZBRA indicates a somewhat cheap valuation: ZBRA is cheaper than 75.81% of the companies listed in the same industry.
  • ZBRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZBRA is cheaper than 87.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.54
EV/EBITDA 13.38
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ZBRA has a very decent profitability rating, which may justify a higher PE ratio.
  • ZBRA's earnings are expected to grow with 13.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.92
PEG (5Y)3.08
EPS Next 2Y13.55%
EPS Next 3Y13.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZBRA Dividend Analysis

5.1 Amount

  • No dividends for ZBRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZBRA Fundamentals: All Metrics, Ratios and Statistics

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (3/9/2026, 12:40:34 PM)

211.77

-7.88 (-3.59%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners98.81%
Inst Owner Change-1.34%
Ins Owners0.77%
Ins Owner Change4.51%
Market Cap10.42B
Revenue(TTM)5.40B
Net Income(TTM)419.00M
Analysts79.23
Price Target343.86 (62.37%)
Short Float %4.13%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-1.97%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)3.72%
Min EPS beat(4)-1.97%
Max EPS beat(4)8.97%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)8
Avg EPS beat(12)3.99%
EPS beat(16)11
Avg EPS beat(16)2.96%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.49%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)-1.21%
PT rev (1m)0.14%
PT rev (3m)-6.03%
EPS NQ rev (1m)2.86%
EPS NQ rev (3m)2.95%
EPS NY rev (1m)1.57%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)2.58%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.53%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 13.37
Fwd PE 11.67
P/S 1.93
P/FCF 12.54
P/OCF 11.36
P/B 2.9
P/tB N/A
EV/EBITDA 13.38
EPS(TTM)15.84
EY7.48%
EPS(NY)18.14
Fwd EY8.57%
FCF(TTM)16.89
FCFY7.98%
OCF(TTM)18.64
OCFY8.8%
SpS109.7
BVpS72.94
TBVpS-39.6
PEG (NY)0.92
PEG (5Y)3.08
Graham Number161.23
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROCE 12.03%
ROIC 9.5%
ROICexc 9.68%
ROICexgc 63.89%
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
FCFM 15.4%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ROICexc(3y)9.75%
ROICexc(5y)12.66%
ROICexgc(3y)53.88%
ROICexgc(5y)104.36%
ROCE(3y)11.5%
ROCE(5y)15.08%
ROICexgc growth 3Y-21.35%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.63%
ROICexc growth 5Y-9.69%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Debt/EBITDA 2.4
Cap/Depr 46.49%
Cap/Sales 1.59%
Interest Coverage 6.2
Cash Conversion 93.1%
Profit Quality 198.33%
Current Ratio 0.97
Quick Ratio 0.58
Altman-Z 3.13
F-Score5
WACC8.85%
ROIC/WACC1.07
Cap/Depr(3y)43.41%
Cap/Depr(5y)39.71%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
EPS Next Y14.52%
EPS Next 2Y13.55%
EPS Next 3Y13.11%
EPS Next 5Y15.22%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%
Revenue Next Year11.43%
Revenue Next 2Y8.45%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%
EBIT growth 1Y4.58%
EBIT growth 3Y-5.1%
EBIT growth 5Y3.15%
EBIT Next Year26.94%
EBIT Next 3Y14.04%
EBIT Next 5Y11.74%
FCF growth 1Y-12.89%
FCF growth 3Y26.25%
FCF growth 5Y-1.47%
OCF growth 1Y-9.48%
OCF growth 3Y23.4%
OCF growth 5Y-0.95%

ZEBRA TECHNOLOGIES CORP-CL A / ZBRA FAQ

Can you provide the ChartMill fundamental rating for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a fundamental rating of 5 / 10 to ZBRA.


Can you provide the valuation status for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a valuation rating of 7 / 10 to ZEBRA TECHNOLOGIES CORP-CL A (ZBRA). This can be considered as Undervalued.


How profitable is ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) stock?

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) has a profitability rating of 7 / 10.


How financially healthy is ZEBRA TECHNOLOGIES CORP-CL A?

The financial health rating of ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) is 4 / 10.